Serum Bone Gla Protein: A Potential Marker of Growth Hormone (GH) Deficiency and the Response to GH Therapy
Authors:
- 1 July 1990
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 71 (1) , 122-126
Abstract
Serum bone Gla protein (BGP), a sensitive and specific biochemical marker of bone formation, was measured in 66 children deficient in GH before and after 3, 6, 9, and 12 months of treatment with biosynthetic human GH. Initial serum BGP levels were significantly lower than those of normal age-matched children. After 3 months of treatment, the mean serum BGP level had increased to normal. There was no relation between baseline serum BGP and the growth response, but the GH-induced increment in serum BGP levels at 3 months was highly significantly related to growth response after 12 months of therapy. The study shows that serum BGP could be a helpful biochemical marker in prediction of the growth response to long term GH therapy.Keywords
This publication has 18 references indexed in Scilit:
- Evaluation of serum osteocalcin as an index of altered bone metabolismEuropean Journal of Pediatrics, 1986
- Effects of local administration of GH and IGF-1 on longitudinal bone growth in ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 1986
- Local Injections of Human or Rat Growth Hormone or of Purified Human Somatomedin-C Stimulate Unilateral Tibial Epiphyseal Growth in Hypophysectomized Rats*Endocrinology, 1985
- SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1984
- The Effect of Growth Hormone Treatment on Somatomedin Levels in Growth Hormone-Deficient Children*The Journal of Clinical Endocrinology & Metabolism, 1982
- Effects of Human Growth Hormone Administration on Serum Somatomedins, Somatomedin Carrier Proteins, and Growth Rates in Children with Growth Hormone Deficiency*The Journal of Clinical Endocrinology & Metabolism, 1982
- Kinetics of the Somatomedin C/Insulin-Like Growth Factor I: Response to Exogenous Growth Hormone (GH) in GH-Deficient Children *The Journal of Clinical Endocrinology & Metabolism, 1982
- Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.Journal of Biological Chemistry, 1981
- Effects of Prolonged Dopamine Infusion on Anterior Pituitary Function in Normal Males*The Journal of Clinical Endocrinology & Metabolism, 1981
- EXPERIENCE WITH HUMAN GROWTH HORMONE IN GREAT BRITAIN: THE REPORT OF THE MRC WORKING PARTYClinical Endocrinology, 1979